Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has dosed its first subject in a Phase 2 clinical tr...

2020-12-07 21:00 3353

JW Therapeutics Presents Data from Pivotal Trial of Relma-cel at the 62nd ASH Annual Meeting

SHANGHAI, Dec. 7, 2020 /PRNewswire/ -- JW Therapeutics (stock code: 2126.HK), a leading clinical stage cell therapy company, presented data from the pivotal study (RELIANCE Trial) of relmacabtagene autoleucel ("relma-cel") under IND pathway at the 62nd American Society of Hematology (ASH) Annual ...

2020-12-07 18:30 2164

GEN inCode Appoints Chief Financial Officer

OXFORD, England, Dec. 7, 2020 /PRNewswire/ -- GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger as Chief Financial Officer to the Company. Paul Foulge...

2020-12-07 15:00 1268

The Mullings Group Opens London Office To Service Talent Acquisitions for Growing MedTech Clientele in U.K., EU and Middle East

LONDON, Dec. 7, 2020 /PRNewswire/ -- The Mullings Group, a leading talent acquisition firm in the U.S. specializing in medical & health technology and life sciences, has opened an office inLondon to service the growing needs of its clientele in the U.K., E.U. and theMiddle East. "We experienced ...

2020-12-07 15:00 1187

YES Partners with Singapore's Gaia Science

FREMONT, Calif., Dec. 7, 2020 /PRNewswire/ -- YES (Yield Engineering Systems, Inc.), a leading manufacturer of process equipment for semiconductor advanced packaging, Life Science and "More-than-Moore" applications, today announced that it has signed an agreement with Gaia Science Pte. Ltd ofSing...

2020-12-07 09:00 1849

Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study

SHANGHAI and HONG KONG, Dec. 7, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and on...

2020-12-07 08:00 3493

CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition

SHANGHAI, Dec. 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, announced updated safety and efficacy results from its ongoing global clinical studies of CT053, an investigational chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed an...

2020-12-06 19:00 3536

Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BCMA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Multiple Myeloma at 2020 ASH Annual Meeting

SUZHOU and SHANGHAI, China, Dec. 5, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced an interim readout to evaluat...

2020-12-06 04:30 3239

Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office

STOCKHOLM, Dec. 5, 2020 /PRNewswire/ -- Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price ofSEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price ofSEK ...

2020-12-05 00:35 5393

I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China

SHANGHAI and GAITHERSBURG, Md., Dec. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced the advancement of clinical dev...

2020-12-04 21:00 8218

Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch

INCHEON, South Korea, Dec. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced the launch of a virtual showroom to provide key features and real-time construction updates of its recently announced Plant 4. The digital showcase also highlights various specs and services that the S...

2020-12-04 20:00 2201

Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch

Indonesia's Government to Continue Improving Competitiveness in Human Capital Against the Backdrop of the Fourth Industrial Revolution and the Demographic Dividend

JAKARTA, Indonesia, Dec. 4, 2020 /PRNewswire/ -- In addition to accelerating national economic recovery in the midst of the Covid-19 pandemic,Indonesia's government continues to support efforts in improving human capital competitiveness. This is done in order to better prepare them in facing the ...

2020-12-04 17:01 2100

Indonesia's Government to Continue Improving Competitiveness in Human Capital Against the Backdrop of the Fourth Industrial Revolution and the Demographic Dividend

Polygiene and Eye-care innovator Body Doctor now increase the range of soothing eye compresses and face masks

STOCKHOLM, Dec. 4, 2020 /PRNewswire/ -- Body Doctor specializes in eye-care, eyelid hygiene products and have transformed the market for eye compresses and continue establishing a pedigree of bringing innovation to the sector with an antibacterial fabric thanks to the partnership with Polygiene®....

2020-12-04 16:23 2434

Ascentage Pharma Appoints Mr. Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives

SUZHOU, China and ROCKVILLE, Md., Dec. 4, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr. Gang Z...

2020-12-04 08:28 2298

Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study

HANGZHOU and SHAOXING, China, Dec. 4, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) announces today that Phase IIa data demonstrated that ASC22 (Envafolimab) is safe and well tolerated in chronic hepatitis B (CHB) patients and Phase IIb clinical trial has been initiated. ASC22 (Envafolima...

2020-12-04 08:00 3449

I Peace, Inc. Obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use

PALO ALTO, Calif., Dec. 3, 2020 /PRNewswire/ -- I Peace, Inc., a Palo Alto -based biotech start-up focusing on Nobel Prize-winning induced pluripotent stem cell (iPSC) technology obtains approval from an independent Institutional Review Board (IRB) for the process of generating iPSCs—including...

2020-12-04 05:00 1187

Aspect Imaging Lauded by Frost & Sullivan for Its Revolutionary Embrace® Neonatal MRI System that Addresses the Key Medical Imaging Challenges of Neonatologists

By eliminating the need to move neonates from the NICU to the radiology department, Aspect Imaging's Embrace enables a safer way to perform the MRI procedure LONDON, Dec. 3, 2020 /PRNewswire/ -- Based on its recent analysis of the global neonatal intensive care unit magnetic resonance imaging (I...

2020-12-03 23:40 1884

Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for COVID-19

Highlights: * The first hospitalized patient with severe COVID-19, treated under an eIND was discharged in 5 days after being treated with Silmitasertib. * The first patient with moderate COVID-19 has enrolled into this clinical trial at the Center for Advanced Research and Education (CARE),G...

2020-12-03 22:17 2217

Drawbridge Health partners with University of Cambridge Researchers for use of OneDraw™ Blood Collection Device in COVID-19 and Other Clinical Studies

MENLO PARK, Calif., Dec. 3, 2020 /PRNewswire/ -- Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit,University of Cambridge (UK) today announced the use of the OneDraw™ Blood Collection Device1 for remote blood sample collection in a large-scale surveillance study currentl...

2020-12-03 22:00 2182

VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors

AUSTIN, Texas, Dec. 3, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced today the...

2020-12-03 21:30 9820

1 ... 588 589 590591592 593 594 ... 808